Seelos Therapeutics SG&A Expense (TTM) Analysis

Seelos Therapeutics Inc (SEEL)

0.504 -0.05 (-9.19%) USD | NASDAQ | Jul 08, 16:00

0.504 0.00 (0.00%) After-Hours: 17:57

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2000. Upgrade now.

Date	Value
March 31, 2024	11.62M
December 31, 2023	12.58M
September 30, 2023	12.59M
June 30, 2023	12.26M
March 31, 2023	12.37M
December 31, 2022	12.30M
September 30, 2022	17.37M
June 30, 2022	16.94M
March 31, 2022	16.52M
December 31, 2021	15.02M
September 30, 2021	9.205M
June 30, 2021	9.048M
March 31, 2021	8.459M
December 31, 2020	7.775M
September 30, 2020	6.894M
June 30, 2020	6.239M
March 31, 2020	6.053M
December 31, 2019	7.559M
September 30, 2019	12.63M
June 30, 2019	12.13M
March 31, 2019	12.52M
December 31, 2018	11.33M
September 30, 2018	7.536M
June 30, 2018	8.377M
March 31, 2018	7.904M

Date	Value
December 31, 2017	7.21M
September 30, 2017	6.699M
June 30, 2017	6.493M
March 31, 2017	7.013M
December 31, 2016	7.796M
September 30, 2016	8.235M
June 30, 2016	9.097M
March 31, 2016	9.644M
December 31, 2015	10.52M
September 30, 2015	10.94M
June 30, 2015	11.25M
March 31, 2015	11.46M
December 31, 2014	11.42M
September 30, 2014	11.76M
June 30, 2014	11.91M
March 31, 2014	12.79M
December 31, 2013	13.55M
September 30, 2013	15.47M
June 30, 2013	16.36M
March 31, 2013	15.92M
December 31, 2012	15.34M
September 30, 2012	12.90M
June 30, 2012	11.41M
March 31, 2012	11.78M
December 31, 2011	11.45M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

6.053M

Minimum

Mar 2020

17.37M

Maximum

Sep 2022

11.23M

Average

12.26M

Median

Jun 2023

SG&A Expense (TTM) Benchmarks